V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280009365 | 280011472 | 1.7 | 54.3 | Palliative (P) | null | 2016-06-26 | ETOPOSIDE | N | N | 280018423 | LIPOSOMAL DOXORUBICIN |
| 280009366 | 280011472 | 1.67 | null | Palliative (P) | 2015-06-05 | 2015-06-12 | BENDAMUSTINE + RITUXIMAB | N | N | 280018423 | IPILIMUMAB |
| 280009367 | 280006626 | null | 97.4 | Palliative (P) | 2015-12-25 | 2016-01-02 | Carboplatin + Cetux + FU (>Cycle 2) | Y | N | 280018765 | IRINOTECAN + VINCRISTINE |
| 280009368 | 280006627 | 1.8 | null | null | null | 2019-01-28 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | null | 280018844 | NIVOLUMAB |
| 280009369 | 280006627 | 1.71 | 19.1 | Disease modification (D) | 2016-04-12 | 2016-04-20 | Dactinomycin + Vincristine | N | N | 280018844 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280009370 | 280006627 | 1.73 | null | Palliative (P) | 2015-01-20 | 2015-03-13 | Cyclophosphamide High Dose | 2 | N | 280018844 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280009371 | 280006627 | 1.61 | 81 | Palliative (P) | null | 2014-10-04 | Capecitabine + Oxaliplatin 21day | N | N | 280018844 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 280009372 | 280006628 | 1.65 | 89.8 | Disease modification (D) | 2016-11-09 | 2016-12-17 | Cyclophosphamide + Vincristine | N | N | 280019073 | IDELALISIB |
| 280009373 | 280006632 | null | 81.8 | Palliative (P) | null | 2017-08-15 | ETOPOSIDE | null | null | 280019109 | IVADO |
| 280009374 | 280006632 | null | 10.2 | Palliative (P) | 2013-12-31 | 2014-01-02 | NIVOLUMAB | null | Y | 280019109 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280009375 | 280006633 | null | 19.9 | Palliative (P) | 2015-01-28 | 2015-02-08 | BCG Intravesical | N | N | 280019158 | AVELUMAB |
| 280009376 | 280009450 | 2 | 93 | Palliative (P) | 2017-02-10 | 2017-03-07 | PACLITAXEL + TRASTUZUMAB | N | N | 280019202 | CARBOPLATIN + CETUXIMAB + FU |
| 280009377 | 280006634 | 1.72 | 87 | Palliative (P) | 2013-03-11 | 2013-04-27 | VIDE | 02 | N | 280019252 | CARBO + FLUOROURACIL |
| 280009378 | 280006634 | 0.62 | 67.4 | Curative (C) | 2017-12-14 | 2017-12-14 | Cyclophosphamide PO +Vinorelbine IV | N | N | 280019252 | CARBOPLATIN + CETUXIMAB + FU |
| 280009379 | 280009452 | 1.7 | 62.1 | Adjuvant (A) | 2016-07-25 | 2016-07-25 | Capecitabine + Streptozocin | N | N | 280019281 | EURAMOS TRIAL |
| 280009380 | 280009452 | 1.55 | 82.7 | Curative (C) | 2015-06-26 | 2015-07-03 | EURAMOS TRIAL | Y | N | 280019281 | IRINOTECAN + VINCRISTINE |
| 280009381 | 280006636 | 1.8 | null | Neo-adjuvant (N) | 2013-11-21 | 2013-12-14 | VIDE | 2 | N | 280019385 | CAPECITABINE + CISPLATIN |
| 280009382 | 280006637 | 1.58 | 41.5 | Palliative (P) | 2016-09-05 | 2016-09-05 | DACTINOMYCIN + CYCLO + VINCRISTINE | N | N | 280019450 | VIDE |
| 280009383 | 280006640 | 1.78 | 94.7 | Palliative (P) | 2014-03-23 | 2014-03-30 | Capecitabine | N | N | 280019477 | CARBO + FLUOROURACIL |
| 280009384 | 280006642 | 1.82 | 69.3 | Curative (C) | 2015-04-22 | 2015-04-29 | VIA (Ifos 1.5g/m2) | N | N | 280019477 | DOCETAXEL |
| 280009385 | 280006643 | 1.62 | 79.8 | Curative (C) | 2013-03-24 | 2013-10-01 | Bendamustine+Rituximab(Sub Courses) | Y | null | 280019631 | IRINOTECAN + VINCRISTINE |
| 280009386 | 280006644 | 1.7 | null | Curative (C) | 2015-09-08 | 2015-09-08 | TRASTUZUMAB | Y | N | 280019640 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280009387 | 280006645 | 1.9 | 60.5 | Palliative (P) | 2018-07-23 | 2018-07-30 | Fluorouracil + Folinic Acid Weekly | 2 | N | 280019697 | FLUOROURACIL + MITOMYCIN + RT |
| 280009388 | 280006646 | 1.65 | 19.15 | Palliative (P) | null | 2016-09-20 | VIDE | null | null | 280019845 | IPILIMUMAB |
| 280009389 | 280006647 | null | 64.1 | Curative (C) | 2014-01-25 | 2014-02-24 | VINCRISTINE | N | N | 280019933 | CISPLATIN + DOCETAXEL + FLUOROURACIL + RT |
| 280009390 | 280006650 | 1.8 | 88.35 | Palliative (P) | 2016-04-29 | 2016-05-04 | Cyclophosphamide + Vincristine | N | N | 280020052 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280009391 | 280006651 | 1.82 | 49 | Palliative (P) | 2016-08-10 | 2016-08-15 | CARBOPLATIN + FLUOROURACIL | 2 | Y | 280020080 | VINORELBINE |
| 280009392 | 280006652 | null | null | Palliative (P) | 2015-08-09 | 2015-09-01 | EOX | N | N | 280020096 | NIVOLUMAB |
| 280009393 | 280011796 | 1.81 | 115 | Palliative (P) | null | 2018-10-13 | BCG Intravesical | null | null | 280020201 | IFOSFAMIDE + VINCRISTINE |
| 280009394 | 280006656 | 1.7 | null | Curative (C) | 2017-12-27 | 2017-12-30 | Cyclophosphamide + Topotecan | N | N | 280020258 | GEMCARBO |
| 280009395 | 280009457 | 1.7 | 87.3 | Adjuvant (A) | 2019-03-30 | 2019-03-30 | CMV | 02 | N | 280020346 | CAPECITABINE |
| 280009396 | 280006658 | 1.77 | null | Palliative (P) | null | 2018-01-18 | Erlotinib | N | N | 280020428 | BCG |
| 280009397 | 280006659 | 1.8 | null | Palliative (P) | 2015-03-01 | 2015-07-26 | Cisplatin + Fluorouracil + RT 5day | N | null | 280020449 | DACTINOMYCIN + VINCRISTINE |
| 280009398 | 280006662 | 1.79 | 85 | Palliative (P) | 2017-05-26 | 2017-06-24 | CARBOPLATIN + VINORELBINE | N | N | 280020449 | DABRAFENIB + TRAMETINIB |
| 280009399 | 280006662 | 1.79 | null | Palliative (P) | 2013-11-19 | 2014-01-28 | CARBOPLATIN + CETUXIMAB + FU | 02 | N | 280020449 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009400 | 280006664 | 1.54 | 100.5 | Palliative (P) | 2014-10-01 | 2014-10-03 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | 280020538 | VINCRISTINE |
| 280009401 | 280006666 | null | 77 | Palliative (P) | 2015-06-27 | 2015-07-13 | FLUOROURACIL + MITOMYCIN | N | N | 280020664 | BUSULFAN + MELPHALAN |
| 280009402 | 280006667 | 1.83 | 68.4 | Palliative (P) | 2017-12-17 | 2018-01-11 | Hydroxycarbamide | N | null | 280020669 | IMATINIB |
| 280009403 | 280006673 | 1.73 | 89.2 | null | 2014-09-14 | 2014-09-21 | Cisplatin + Fluorouracil + RT 5day | N | N | 280020676 | IVADO |
| 280009404 | 280006674 | 1.62 | null | Palliative (P) | 2016-04-13 | 2016-05-10 | Rituximab (Maintenance) | 2 | N | 280020683 | RITUXIMAB |
| 280009405 | 280006674 | 1.8 | 91.6 | null | 2014-05-22 | 2014-05-27 | CAPECITABINE + OXALIPLATIN | 2 | N | 280020683 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE |
| 280009406 | 280009465 | 1.89 | 78 | Palliative (P) | 2018-08-19 | 2018-08-20 | ECX | 02 | N | 280020957 | DACARBAZINE |
| 280009407 | 280009466 | null | 68.4 | Palliative (P) | 2014-06-18 | 2015-10-24 | CAPECITABINE + TEMOZOLOMIDE | N | N | 280021107 | VINCRISTINE |
| 280009408 | 280009466 | null | 94 | Palliative (P) | 2015-09-26 | 2015-09-27 | CARBOPLATIN + VINORELBINE | N | N | 280021107 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280009409 | 280006678 | 1.85 | null | Curative (C) | 2015-05-26 | 2015-05-28 | ECX | null | N | 280021294 | BUSULFAN + MELPHALAN |
| 280009410 | 280006679 | null | 109.8 | Adjuvant (A) | 2019-04-04 | 2019-04-05 | CAPECITABINE + IRINOTECAN | N | N | 280021312 | DACTINOMYCIN + VINCRISTINE |
| 280009411 | 280009467 | null | 52 | Not known (9) | 2018-02-21 | 2018-03-11 | Mitomycin Intravesical | N | null | 280021328 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280009412 | 280006682 | 1.55 | 85.1 | Neo-adjuvant (N) | 2015-08-30 | 2015-08-30 | CARBOPLATIN + FLUOROURACIL | 02 | N | 280021363 | IVADO |
| 280009413 | 280006683 | 1.69 | null | Palliative (P) | 2018-12-02 | 2018-12-09 | Capecitabine (21days) + Carboplatin | N | null | 280021363 | IRINOTECAN + VINCRISTINE |
| 280009414 | 280006683 | 1.82 | 86.3 | Curative (C) | 2018-12-30 | 2019-01-14 | CAPECITABINE + CARBOPLATIN | 2 | N | 280021363 | COMPARE TRIAL |